Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific

Virology Journal

Volumn 9, Issue , 2012, Pages

  Levitz, Ruth ^a   Wattier, Rachel ^b,c   Phillips, Pamela ^a   Solomon, Alexandra ^a   Lawler, Jessica ^a   Lazar, Isaac ^b,d   Weibel, Carla ^b   Kahn, Jeffrey S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CCL5; Clinical isolates; IL 6; RANTES; Respiratory syncytial virus; Respiratory syncytial virus genome

Indexed keywords

INTERLEUKIN 6; RANTES;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

CELL LINE; CHEMOKINE CCL5; CHILD, PRESCHOOL; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INTERLEUKIN-6; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRULENCE;

CERCOPITHECINE HERPESVIRUS 1; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SUBGROUP A; SUBGROUP B;

EID: 84865847461     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-190     Document Type: Article

References (46)

1. Respiratory syncytial virus and parainfluenza virus. Hall CB, N Engl J Med 2001 344 25 1917 1928 10.1056/NEJM200106213442507 11419430
2. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, McIntosh K, J Infect Dis 1985 151 4 626 633 10.1093/infdis/151.4.626 2579169
3. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, Tsou C, Anderson LJ, J Infect Dis 2000 181 6 1891 1896 10.1086/315508 10837167
4. Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. Zlateva KT, Lemey P, Moes E, Vandamme AM, Van Ranst M, J Virol 2005 79 14 9157 9167 10.1128/JVI.79.14.9157- 9167.2005 15994810
5. Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. Zlateva KT, Lemey P, Vandamme AM, Van Ranst M, J Virol 2004 78 9 4675 4683 10.1128/JVI.78.9.4675-4683.2004 15078950
6. Cytokines and respiratory syncytial virus infection. Tripp RA, Oshansky C, Alvarez R, Proc Am Thorac Soc 2005 2 2 147 149 10.1513/pats.200502-014AW 16113483
7. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. Miller AL, Bowlin TL, Lukacs NW, J Infect Dis 2004 189 8 1419 1430 10.1086/382958 15073679
8. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Kong X, San Juan H, Kumar M, Behera AK, Mohapatra A, Hellermann GR, Mane S, Lockey RF, Mohapatra SS, Biochem Biophys Res Commun 2003 2. 616 p. 622
9. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Hornsleth A, Klug B, Nir M, Johansen J, Hansen KS, Christensen LS, Larsen LB, Pediatr Infect Dis J 1998 17 12 1114 1121 10.1097/00006454-199812000-00003 9877358
10. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O, Pediatr Infect Dis J 1999 18 2 115 122 10.1097/00006454-199902000-00007 10048682
11. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. Hornsleth A, Loland L, Larsen LB, J Clin Virol 2001 21 2 163 170 10.1016/S1386-6532(01)00159- 7 11378497
12. Correlation between respiratory syncytial virus genotype and severity of illness. Martinello RA, Chen MD, Weibel C, Kahn JS, J Infect Dis 2002 186 6 839 842 10.1086/342414 12198620
13. Respiratory syncytial virus genotypes and disease severity among children in hospital. Fletcher JN, Smyth RL, Thomas HM, Ashby D, Hart CA, Arch Dis Child 1997 77 6 508 511 10.1136/adc.77.6.508 9496185
14. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. Gilca R, De Serres G, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, Dery P, Boivin G, J Infect Dis 2006 193 1 54 58 10.1086/498526 16323132
15. Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations. Venter M, Collinson M, Schoub BD, J Med Virol 2002 68 3 452 461 10.1002/jmv.10225 12226836
16. Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. Cane PA, Pringle CR, J Virol 1995 69 5 2918 2925 7707517
17. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Johnson PR, Spriggs MK, Olmsted RA, Collins PL, Proc Natl Acad Sci U S A 1987 84 16 5625 5629 10.1073/pnas.84.16.5625 2441388
18. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. Trento A, Galiano M, Videla C, Carballal G, Garcia-Barreno B, Melero JA, Palomo C, J Gen Virol 2003 84 Pt 11 3115 3120 14573817
19. Replacement of previously circulating respiratory syncytial virus subtype B strains with the BA genotype in South Africa. van Niekerk S, Venter M, J Virol 2011 85 17 8789 8797 10.1128/JVI.02623-10 21715483
20. Pathogenesis of respiratory syncytial virus infection. Tripp RA, Viral Immunol 2004 17 2 165 181 10.1089/0882824041310513 15279697
21. Respiratory syncytial virus and other respiratory viruses. Welliver RC, Pediatr Infect Dis J 2003 22 2 Supp. S6 p. S10 discussion S10-2
22. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Graham BS, Johnson TR, Peebles RS, Immunopharmacology 2000 48 3 237 247 10.1016/S0162-3109(00)00233-2 10960663
23. Epithelial regulation of innate immunity to respiratory syncytial virus. Garofalo RP, Haeberle H, Am J Respir Cell Mol Biol 2000 23 5 581 585 11062135
24. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Lukacs NW, Moore ML, Rudd BD, Berlin AA, Collins RD, Olson SJ, Ho SB, Peebles RS Jr, Am J Pathol 2006 169 3 977 986 10.2353/ajpath.2006.051055 16936271
25. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE Jr, Goleniewska K, Williams JV, Collins PL, Peebles RS Jr, J Virol 2009 83 9 4185 4194 10.1128/JVI.01853-08 19211758
26. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Villenave R, O'Donoghue D, Thavagnanam S, Touzelet O, Skibinski G, Heaney LG, McKaigue JP, Coyle PV, Shields MD, Power UF, Virol J 2011 8 43 10.1186/1743-422X-8-43 21272337
27. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, Lee S, Goleniewska K, Pretto C, Williams JV, Hotard A, Sherrill TP, Peebles RS Jr, Moore ML, J Virol 2011 85 12 5782 5793 10.1128/JVI.01693-10 21471228
28. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalica Z, Garofalo RP, J Infect Dis 2002 186 9 1199 1206 10.1086/344644 12402188
29. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA, J Virol 2001 75 22 10730 10737 10.1128/JVI.75.22.10730-10737.2001 11602714
30. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Kapadia S, Trecki J, Skoner DP, Hum Immunol 2003 64 3 338 344 10.1016/S0198-8859(02)00827-3 12590978
31. Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults. Gentile DA, Doyle WJ, Zeevi A, Piltcher O, Skoner DP, Hum Immunol 2003 64 1 93 98 10.1016/S0198-8859(02)00705-X 12507818
32. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ, Nat Immunol 2001 2 8 732 738 10.1038/90675 11477410
33. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. Sparer TE, Matthews S, Hussell T, Rae AJ, Garcia-Barreno B, Melero JA, Openshaw PJ, J Exp Med 1998 187 11 1921 1926 10.1084/jem.187.11.1921 9607931
34. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. Tebbey PW, Hagen M, Hancock GE, J Exp Med 1998 188 10 1967 1972 10.1084/jem.188.10.1967 9815273
35. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. Varga SM, Wissinger EL, Braciale TJ, J Immunol 2000 165 11 6487 6495 11086089
36. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. Tripp RA, Jones L, Anderson LJ, J Virol 2000 74 13 6227 6229 10.1128/JVI.74.13.6227-6229.2000 10846112
37. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Polack FP, Irusta PM, Hoffman SJ, Schiatti MP, Melendi GA, Delgado MF, Laham FR, Thumar B, Hendry RM, Melero JA, Karron RA, Collins PL, Kleeberger SR, Proc Natl Acad Sci U S A 2005 102 25 8996 9001 10.1073/pnas.0409478102 15956195
38. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Arnold R, Konig B, Werchau H, Konig W, Virology 2004 330 2 384 397 10.1016/j.virol.2004. 10.004 15567433
39. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Whitehead SS, Firestone CY, Collins PL, Murphy BR, Virology 1998 247 2 232 239 10.1006/viro.1998.9248 9705916
40. Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. Martinez I, Lombardia L, Garcia-Barreno B, Dominguez O, Melero JA, J Gen Virol 2007 88 Pt 2 570 581 17251576
41. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus. Jiang Z, Kunimoto M, Patel JA, J Virol 1998 72 3 2496 2499 9499112
42. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Pascu M, Martus P, Hohne M, Wiedenmann B, Hopf U, Schreier E, Berg T, Gut 2004 53 9 1345 1351 10.1136/gut.2003.031336 15306598
43. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Dunfee RL, Thomas ER, Gorry PR, Wang J, Taylor J, Kunstman K, Wolinsky SM, Gabuzda D, Proc Natl Acad Sci U S A 2006 103 41 15160 15165 10.1073/pnas.0605513103 17015824
44. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, Garcia-Sastre A, Science 2005 310 5745 77 80 10.1126/science.1119392 16210530
45. Hsiung GD, Fong CKY, Landry ML, Hsiung's Diagnostic Virology Yale University Press, New Haven 4 1994 23009149
46. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Krempl CD, Lamirande EW, Collins PL, Virus Genes 2005 30 2 237 249 10.1007/s11262-004-5631-4 15744580